Regent Pacific Group Limited (RPGLF)

Market Cap	37.70M +247.4%
Revenue (ttm)	833.00K +535.9%
Net Income	-4.08M
EPS	-0.02
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	69,210
Average Volume	14,557
Open	0.1250
Previous Close	0.1250
Day's Range	0.1250 - 0.1250
52-Week Range	0.0007 - 0.4333
Beta	1.35
RSI	48.01
Earnings Date	Mar 27, 2026

About Regent Pacific Group

Regent Pacific Group Limited, an investment holding company, focuses on healthcare and life sciences sectors in Europe, the United States, and the Asia Pacific. The company operates through Biopharma and Corporate Investment segments. It is involved in the research, development, manufacturing, marketing, and sale of pharmaceutical products for the treatment and management of urological disorders; and development of AI system for the field of biological aging clocks, at the molecular, cellular, tissue, organ, system, physiological, and psycholog...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1991
• Employees: 17
• Stock Exchange: OTCMKTS
• Ticker Symbol: RPGLF

Financial Performance

In 2024, Regent Pacific Group's revenue was $719,000, an increase of 147.08% compared to the previous year's $291,000. Losses were -$4.48 million, -82.11% less than in 2023.